DRKS00032767RecruitingUnknown
Deep-phenotyping and personalized therapy of patients with irritable bowel syndrome - PIONEER-IBS
niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik0 sites75 target enrollmentStarted: October 20, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 75
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •* Irritable bowel syndrome according to ROM-IV criteria,
- •* Irritable bowel syndrome in clinical assessment,
- •* Patients who agree to participate in the study for at least 5 months,
- •* Written informed consent
Exclusion Criteria
- •* Severe psychopathology preventing group therapy (e.g. acute schizophrenic disorder, acute suicidality, current substance dependence (alcohol/drugs)).
- •* Psychopathology preventing short-term EMDR treatment (e.g. severe dissociative symptoms (DES-II >25%), complex post-traumatic stress disorder).
- •* Severe comorbid organic disorder preventing participation (e.g. palliative terminal cancer, serious nephrological, hepatic, cardiovascular or neurological disease).
- •*Pregnancy
Investigators
Similar Trials
Enrolling By Invitation
Not Applicable
PATient based phenotyping and evaluation of therapy for Rare Epilepsiesgenetic epilepsyORPHA:101998 Rare epilepsyORPHA:544254 SYNGAP1-related developmental and epileptic encephalopathyG40EpilepsyDRKS00032075Institut für Rehabilitation, Transition und Palliation von neurologisch kranken Kindern der Paracelsus Medizinischen Privatuniversität Salzburg an der Schön Klinik Vogtareuth3,000
Enrolling By Invitation
Not Applicable
PATient based phenotyping and evaluation of therapy for RASopathies within the framework of the collaborative project EURAS – EURopean network for neurodevelopmental RASopathiesQ87.8Other specified congenital malformation syndromes, not elsewhere classifiedDRKS00032923Institut für Humangenetik der medizinischen Fakultät der Otto-von-Guericke-Universität Magdeburg3,000
Not yet recruiting
Not Applicable
Clinical Deep Phenotyping of Treatment Response in Schizophrenia (CDP-STAR) StudySchizophreniaDRKS00034820Klinik für Psychiatrie und Psychotherapie der LMU München352
Not yet recruiting
Unknown
Clinical, biochemical and liver tissue changes in Hepatitis-B Gray zone patients and determine eligibility for treatment thereof.CTRI/2023/12/060743I.P.G.M.R, Kolkata
Active, not recruiting
Not Applicable
Exploring detailed patient-specific biological analyses to personalise treatment in inflammatory bowel diseaseDigestive SystemCrohn’s disease, ulcerative colitisInflammatory Bowel DiseaseISRCTN65030013Imperial College London468